share_log
Moomoo 24/7 ·  Apr 9 08:29
Molecular Templates Shares Are Trading Higher After the Company Announced That It Will Present Interim Data From Its MT-6402 Phase I Study in Patients With PD-L1+ Solid Tumors at the 2024 AACR Annual Meeting
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment